Gestational Diabetes May Indicate Future Subclinical Renal Issues

Share this content:
Gestational Diabetes May Indicate Future Subclinical Renal Issues
Gestational Diabetes May Indicate Future Subclinical Renal Issues

THURSDAY, May 10, 2018 (HealthDay News) -- Gestational diabetes mellitus (GDM) may be an early indicator of subsequent subclinical renal dysfunction, according to a study published online May 4 in Diabetes Care.

Shristi Rawal, Ph.D., from the National Institutes of Health in Bethesda, Md., and colleagues used data from the Diabetes & Women's Health study (2012 to 2016) to examine the independent and joint associations of GDM and subsequent diabetes with long-term renal function among 607 women and 619 women without GDM participating in the Danish National Birth Cohort (1996 to 2002).

The researchers found that, compared with women without GDM or subsequent diabetes, women with a history of GDM had significantly higher estimated glomerular filtration rate, even if they had not subsequently developed diabetes. Women with a GDM history who later developed diabetes (183 women) also had a significantly higher urinary albumin-to-creatinine ratio (UACR) and an increased risk of elevated UACR (adjusted relative risk, 2.3) versus women with neither. When adjusting for prepregnancy body mass index and hypertension, among other potential confounders, GDM without subsequent diabetes was not related to UACR.

"These findings suggest that women with GDM-complicated pregnancies may represent a high-risk group that could benefit from regular monitoring for early-stage renal damage, timely detection of which may help clinicians initiate treatment to prevent or delay further disease progression," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »